| abstract |
The present disclosure relates to a pharmaceutical composition comprising an anti-IL-5 antibody and uses thereof. Specifically, the present disclosure relates to a pharmaceutical composition comprising an IL-5 antibody or antigen-binding fragment thereof in a buffer. In addition, the pharmaceutical composition also comprises a sugar and non-ionic surfactant. The pharmaceutical compositions of the present disclosure have good stability. |